Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion

Recruiting N/A Interventional Study
Acute Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
386 (estimated)
Sponsor
Jinling Hospital, China · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Stroke is one of the most important diseases endangering the health and quality of life of Chinese people. Acute ischemic stroke (AIS) is commonly caused by cerebrovascular stenosis or occlusion. The most effective treatment for AIS is timely and successful angiographic reperfusion. Due to the large diameter and obvious positioning of bilateral femoral arteries, the transfemoral artery (TFA) usin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Acute ischemic stroke in the posterior circulation confirmed by symptoms and imaging examinations. 2. Basilar artery occlusion confirmed by computed tomographic angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA). 3. Age ≥ 18 year…
Contacts

Rui Liu, MD

+86 2584801861

liurui8616@163.com

CONTACT

Xinfeng Liu, MD

+86 2584801861

xfliu2@vip.163.com

CONTACT